Leen De Rycke
Department of Rheumatology
Ghent University Hospital
De Pintelaan 185
9000 Ghent
Belgium
Name/email consistency: high
- Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis. De Rycke, L., Verhelst, X., Kruithof, E., Van den Bosch, F., Hoffman, I.E., Veys, E.M., De Keyser, F. Ann. Rheum. Dis. (2005)
- Differential expression and response to anti-TNFalpha treatment of infiltrating versus resident tissue macrophage subsets in autoimmune arthritis. De Rycke, L., Baeten, D., Foell, D., Kruithof, E., Veys, E.M., Roth, J., De Keyser, F. J. Pathol. (2005)
- Infliximab, but not etanercept, induces IgM anti-double-stranded DNA autoantibodies as main antinuclear reactivity: biologic and clinical implications in autoimmune arthritis. De Rycke, L., Baeten, D., Kruithof, E., Van den Bosch, F., Veys, E.M., De Keyser, F. Arthritis Rheum. (2005)
- Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations. De Rycke, L., Peene, I., Hoffman, I.E., Kruithof, E., Union, A., Meheus, L., Lebeer, K., Wyns, B., Vincent, C., Mielants, H., Boullart, L., Serre, G., Veys, E.M., De Keyser, F. Ann. Rheum. Dis. (2004)
